Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [18]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN6213692 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Mitogen-Activated Protein Kinase 3 (MAPK3) (N-Term) antibody
- Antibody type
- Polyclonal
- Description
- Affinity purification
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Epitope
- N-Term
- Isotype
- IgG
- Vial size
- 20 μL
- Storage
- -20°C/-80°C
- Handling
- Avoid freeze / thaw cycles
Submitted references KAT5 silencing induces apoptosis of GBC-SD cells through p38MAPK-mediated upregulation of cleaved Casp9.
Activation of AKT/ERK confers non-small cell lung cancer cells resistance to vinorelbine.
RAF1-MEK1-ERK/AKT axis may confer NSCLC cell lines resistance to erlotinib.
Feng FL, Yu Y, Liu C, Zhang BH, Cheng QB, Li B, Tan WF, Luo XJ, Jiang XQ
International journal of clinical and experimental pathology 2014;7(1):80-91
International journal of clinical and experimental pathology 2014;7(1):80-91
Activation of AKT/ERK confers non-small cell lung cancer cells resistance to vinorelbine.
Fan DP, Zhang YM, Hu XC, Li JJ, Zhang W
International journal of clinical and experimental pathology 2014;7(1):134-43
International journal of clinical and experimental pathology 2014;7(1):134-43
RAF1-MEK1-ERK/AKT axis may confer NSCLC cell lines resistance to erlotinib.
Xu ZH, Hang JB, Hu JA, Gao BL
International journal of clinical and experimental pathology 2013;6(8):1493-504
International journal of clinical and experimental pathology 2013;6(8):1493-504
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC